AT513842T - new dihydropseudoerythromycinderivate - Google Patents

new dihydropseudoerythromycinderivate


Publication number
AT513842T AT06821966T AT06821966T AT513842T AT 513842 T AT513842 T AT 513842T AT 06821966 T AT06821966 T AT 06821966T AT 06821966 T AT06821966 T AT 06821966T AT 513842 T AT513842 T AT 513842T
Prior art keywords
Prior art date
Application number
Other languages
German (de)
Satoshi Omura
Toshiaki Sunazuka
Kenichiro Nagai
Hideaki Shima
Haruko Yamabe
Original Assignee
Kitasato Inst
Aphoenix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to JP2005301070 priority Critical
Application filed by Kitasato Inst, Aphoenix Inc filed Critical Kitasato Inst
Priority to PCT/JP2006/320888 priority patent/WO2007043710A1/en
Publication of AT513842T publication Critical patent/AT513842T/en



    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
AT06821966T 2005-10-14 2006-10-13 new dihydropseudoerythromycinderivate AT513842T (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2005301070 2005-10-14
PCT/JP2006/320888 WO2007043710A1 (en) 2005-10-14 2006-10-13 Novel dihydropseudoerythromycin derivatives

Publications (1)

Publication Number Publication Date
AT513842T true AT513842T (en) 2011-07-15



Family Applications (1)

Application Number Title Priority Date Filing Date
AT06821966T AT513842T (en) 2005-10-14 2006-10-13 new dihydropseudoerythromycinderivate

Country Status (17)

Country Link
US (1) US8133871B2 (en)
EP (1) EP1950219B1 (en)
JP (1) JP5118973B2 (en)
KR (1) KR101384927B1 (en)
CN (1) CN101326192B (en)
AT (1) AT513842T (en)
AU (1) AU2006300215B2 (en)
BR (1) BRPI0617391A2 (en)
CA (1) CA2625055C (en)
EA (1) EA015737B1 (en)
ES (1) ES2369898T3 (en)
IL (1) IL190643A (en)
MY (1) MY147211A (en)
NZ (1) NZ567772A (en)
UA (1) UA94065C2 (en)
WO (1) WO2007043710A1 (en)
ZA (1) ZA200803414B (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
DE10336400A1 (en) 2003-08-06 2005-03-24 Grünenthal GmbH Abuse-proofed dosage form
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
DE102005005446A1 (en) 2005-02-04 2006-08-10 Grünenthal GmbH Unbreakable dosage forms with delayed release
DE102007011485A1 (en) 2007-03-07 2008-09-11 Grünenthal GmbH Dosage form with impeded abuse
TWI454288B (en) 2008-01-25 2014-10-01 Gruenenthal Chemie Pharmaceutical dosage form
CA2723438C (en) 2008-05-09 2016-10-11 Gruenenthal Gmbh Process for the preparation of an intermediate powder formulation and a final solid dosage form under usage of a spray congealing step
EP2456424B1 (en) 2009-07-22 2013-08-28 Grünenthal GmbH Oxidation-stabilized tamper-resistant dosage form
PE10672012A1 (en) 2009-07-22 2012-09-05 Gruenenthal Chemie Form of controlled release dosage extruded by hot melt
JP5933553B2 (en) 2010-09-02 2016-06-15 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング Abuse-resistant dosage form comprising an anionic polymer
KR20130097202A (en) 2010-09-02 2013-09-02 그뤼넨탈 게엠베하 Tamper resistant dosage form comprising inorganic salt
HUE034711T2 (en) 2011-07-29 2018-02-28 Gruenenthal Gmbh Tamper-resistant tablet providing immediate drug release
US20130225697A1 (en) 2012-02-28 2013-08-29 Grunenthal Gmbh Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
JP6445537B2 (en) 2013-05-29 2018-12-26 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング Modified anti containing one or more particles (tamper-resistant) dosage forms
CA2913209A1 (en) 2013-05-29 2014-12-04 Grunenthal Gmbh Tamper resistant dosage form with bimodal release profile
JP2017518980A (en) 2014-05-12 2017-07-13 グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング Containing tapentadol, modified prevent immediate release capsule formulation
MX2016015417A (en) 2014-05-26 2017-02-22 Grünenthal GmbH Multiparticles safeguarded against ethanolic dose-dumping.
EP3277701A4 (en) * 2015-03-25 2019-03-06 Harvard College Synthesis of desosamines
KR20170139158A (en) 2015-04-24 2017-12-18 그뤼넨탈 게엠베하 Immediately released and prevent the tamper-resistant dosage form extraction solvent

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5106961A (en) * 1987-05-26 1992-04-21 Eli Lilly And Company Erythromycin ring-contracted derivatives
CA2386828C (en) 2000-08-17 2006-01-24 The Kitasato Institute Novel pseudoerythromycin derivatives
US20040067896A1 (en) * 2002-07-25 2004-04-08 The Kitasato Institute Novel pseudoerythromycin derivatives
AU2002225724A1 (en) * 2000-12-01 2002-07-08 Kosan Biosciences, Inc. Motilide compounds
US20020094962A1 (en) * 2000-12-01 2002-07-18 Gary Ashley Motilide compounds
AU2002368309A1 (en) * 2002-10-29 2004-05-25 The Kitasato Institute Novel macrolide derivatives havaing effect of potentiating antifungal activity

Also Published As

Publication number Publication date
US20090131341A1 (en) 2009-05-21
EA200801083A1 (en) 2009-02-27
CN101326192A (en) 2008-12-17
EA015737B1 (en) 2011-10-31
AU2006300215B2 (en) 2012-06-21
JP5118973B2 (en) 2013-01-16
UA94065C2 (en) 2011-04-11
CA2625055C (en) 2013-12-24
ES2369898T3 (en) 2011-12-07
IL190643D0 (en) 2008-11-03
BRPI0617391A2 (en) 2011-07-26
EP1950219B1 (en) 2011-06-22
CA2625055A1 (en) 2007-04-19
ZA200803414B (en) 2009-09-30
IL190643A (en) 2012-03-29
US8133871B2 (en) 2012-03-13
KR20080064861A (en) 2008-07-09
KR101384927B1 (en) 2014-04-11
JPWO2007043710A1 (en) 2009-07-16
WO2007043710A1 (en) 2007-04-19
WO2007043710A9 (en) 2007-06-07
EP1950219A1 (en) 2008-07-30
CN101326192B (en) 2012-06-20
MY147211A (en) 2012-11-14
EP1950219A4 (en) 2010-02-03
AU2006300215A1 (en) 2007-04-19
NZ567772A (en) 2010-07-30

Similar Documents

Publication Publication Date Title
AT408603T (en) pyrazolylcarboxanilides
DE602006017614D1 (en) Anastomoseverbunddichtung
AT551802T (en) Provider-distance state-bypass
DE602005017262D1 (en) Handstaubsauger
DE602006007822D1 (en) Nrate
AT541571T (en) Diarylhydantoin-connection
AT523504T (en) 1-thio-d-glucitolderivate
DE602006020094D1 (en) Ösennahtanker
AT462445T (en) Prrs-vaccines
AT489405T (en) Hybridcopolymere
AT527526T (en) Photonenzählvorrichtung
DE602006015785D1 (en) L-dimension-scatterometry
AT539711T (en) Hüftpfannenpositionierung
DE602006015986D1 (en) Instant messaging-facility or -serverprotokoll
DE602006007998D1 (en) Styrylsulfidfarbstoffe
AT485852T (en) Oberflächeninjizierungsvorrichtung
DE602006005805D1 (en) Verwirbelungsanordnung
AT415839T (en) Crush-klappstuhl
DE602006006066D1 (en) Ermodulgehäuse
AT447568T (en) new pyrinderivate
DE602006009640D1 (en) Lasermikroporator
AT530519T (en) Cyclobutylaminderivate
AT496729T (en) Schleifagglomeratpolierverfahren
DE602006012058D1 (en) improved elektroblasfaserspinnverfahren
AT477250T (en) Cyanoanthranilamidinsektizide

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1950219

Country of ref document: EP